METROPOLITAN LIFE INSURANCE CO/NY - ADAPTIVE BIOTECHNOLOGIES COR ownership

Back to all holdings Add to watchlist

ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 209 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q2 2023. The put-call ratio across all filers is 0.55 and the average weighting 0.1%.

Links
Filings
External links
Quarter-by-quarter ownership
METROPOLITAN LIFE INSURANCE CO/NY ownership history of ADAPTIVE BIOTECHNOLOGIES COR
ValueSharesWeighting
Q3 2023$39,365
-4.2%
7,223
+17.9%
0.00%0.0%
Q2 2023$41,099
-12.3%
6,125
+15.4%
0.00%0.0%
Q1 2023$46,852
-9.3%
5,306
-21.5%
0.00%0.0%
Q4 2022$51,662
+7.3%
6,7620.0%0.00%0.0%
Q3 2022$48,145
-12.0%
6,7620.0%0.00%0.0%
Q2 2022$54,705
-70.8%
6,762
+1.1%
0.00%
-33.3%
Q4 2021$187,609
-18.0%
6,686
-0.7%
0.00%0.0%
Q3 2021$228,923
-19.5%
6,735
-3.2%
0.00%
-25.0%
Q2 2021$284,345
+27.5%
6,959
+25.6%
0.00%
+33.3%
Q1 2021$223,040
-34.8%
5,540
-4.3%
0.00%
-40.0%
Q4 2020$342,304
+19.3%
5,789
-1.9%
0.01%0.0%
Q3 2020$287,014
+5.0%
5,902
+4.5%
0.01%0.0%
Q2 2020$273,347
+159.7%
5,650
+49.1%
0.01%
+150.0%
Q1 2020$105,258
+266.8%
3,789
+295.1%
0.00%–
Q4 2019$28,693
-4.7%
959
-1.5%
0.00%
-100.0%
Q3 2019$30,097–974–0.00%–
 Download
Other shareholders
ADAPTIVE BIOTECHNOLOGIES COR shareholders Q2 2023
NameSharesValueWeighting ↓
Blue Water Life Science Advisors, LP 3,030,434$23,152,51615.55%
BERYLSON CAPITAL PARTNERS, LLC 289,726$2,213,5076.45%
Matrix Capital Management Company, LP 11,572,590$88,414,5881.69%
Pier Capital, LLC 1,012,401$7,734,7441.27%
VIKING GLOBAL INVESTORS LP 29,993,708$229,151,9291.15%
Eagle Health Investments LP 607,860$4,644,0501.07%
Triatomic Management LP 130,805$999,3500.84%
Aristotle Atlantic Partners, LLC 1,880,567$14,367,5320.80%
Senator Investment Group LP 1,000,000$7,640,0000.69%
ARK Investment Management 9,201,245$70,297,5120.61%
View complete list of ADAPTIVE BIOTECHNOLOGIES COR shareholders